Location · New Haven, CT
Clinical trials in New Haven, CT
189 recruiting studies have a site in New Haven, and 88 of them accept healthy volunteers.
189 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Qurasense
- Location
- New Haven, CT + 2 other US sites
- Eligibility basics
- Ages 25+ · Women only
- RecruitingHealthy volunteers
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
CONMED Corporation
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–70
- RecruitingHealthy volunteers
Molecular Indicators of Systematic Fitness
VO Health, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Merck Sharp & Dohme LLC
- Location
- New Haven, CT + 70 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Bristol-Myers Squibb
- Location
- New Haven, CT + 18 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- New Haven, CT + 118 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Novartis Pharmaceuticals
- Location
- New Haven, CT + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- New Haven, CT + 24 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- New Haven, CT + 21 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- New Haven, CT + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals
- Location
- New Haven, CT + 18 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions
RapidPulse, Inc
- Location
- New Haven, CT + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 1/Phase 2
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Regeneron Pharmaceuticals
- Location
- New Haven, CT + 16 other US sites
- Eligibility basics
- Ages 2+ · Men only
- RecruitingPhase 2/Phase 3
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
Priovant Therapeutics, Inc.
- Location
- New Haven, CT + 34 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sanofi
- Location
- New Haven, CT + 126 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- New Haven, CT + 58 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Merck Sharp & Dohme LLC
- Location
- New Haven, CT + 34 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 3
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
Sanofi
- Location
- New Haven, CT + 26 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated…
Pulnovo Medical, Inc.
- Location
- New Haven, CT + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Strategy for Improving Stroke Treatment Response
Translational Sciences, Inc.
- Location
- New Haven, CT + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Hoffmann-La Roche
- Location
- New Haven, CT + 67 other US sites
- Eligibility basics
- Ages 50–90
- RecruitingPhase 2/Phase 3
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Cabaletta Bio
- Location
- New Haven, CT + 9 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
- Location
- New Haven, CT + 27 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Rein Therapeutics
- Location
- New Haven, CT + 19 other US sites
- Eligibility basics
- Ages 40+